Lantheus (LNTH) Earning Positive News Coverage, Report Shows

News articles about Lantheus (NASDAQ:LNTH) have been trending positive this week, according to Accern Sentiment Analysis. Accern identifies negative and positive media coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Lantheus earned a news sentiment score of 0.28 on Accern’s scale. Accern also assigned media coverage about the medical equipment provider an impact score of 46.1848014996733 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

Shares of Lantheus (LNTH) opened at $20.50 on Wednesday. Lantheus has a 12 month low of $9.25 and a 12 month high of $24.45. The firm has a market cap of $770.75, a price-to-earnings ratio of 25.31, a PEG ratio of 1.33 and a beta of 0.95. The company has a quick ratio of 2.46, a current ratio of 2.96 and a debt-to-equity ratio of -3.41.

LNTH has been the topic of a number of recent research reports. Wells Fargo & Co raised shares of Lantheus from a “market perform” rating to an “outperform” rating in a research note on Thursday, November 2nd. Credit Suisse Group upped their price target on shares of Lantheus from $19.00 to $23.00 and gave the company a “neutral” rating in a research note on Friday, November 3rd. Jefferies Group increased their target price on shares of Lantheus from $22.00 to $27.00 and gave the company a “buy” rating in a research note on Friday, November 3rd. Zacks Investment Research raised shares of Lantheus from a “hold” rating to a “strong-buy” rating and set a $26.00 target price on the stock in a research note on Tuesday, November 7th. Finally, ValuEngine downgraded shares of Lantheus from a “buy” rating to a “hold” rating in a research note on Friday, December 1st. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company. Lantheus has an average rating of “Buy” and a consensus target price of $24.75.

In other news, CFO John W. Crowley sold 3,866 shares of the company’s stock in a transaction dated Tuesday, January 16th. The shares were sold at an average price of $23.52, for a total value of $90,928.32. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Michael P. Duffy sold 21,655 shares of the company’s stock in a transaction dated Wednesday, January 10th. The stock was sold at an average price of $22.40, for a total transaction of $485,072.00. Following the completion of the transaction, the insider now owns 156,784 shares in the company, valued at $3,511,961.60. The disclosure for this sale can be found here. Corporate insiders own 2.30% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This news story was originally published by BBNS and is the property of of BBNS. If you are reading this news story on another domain, it was stolen and republished in violation of US & international trademark and copyright laws. The correct version of this news story can be accessed at https://baseballnewssource.com/markets/lantheus-lnth-earning-positive-news-coverage-report-shows/1895326.html.

Lantheus Company Profile

Lantheus Holdings, Inc is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging.

Insider Buying and Selling by Quarter for Lantheus (NASDAQ:LNTH)

Receive News & Ratings for Lantheus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Red Sox: J.D. Martinez Continues His Physical at Spring Training Facility
Red Sox: J.D. Martinez Continues His Physical at Spring Training Facility
Three-Way Trade Sends Souza to Diamondbacks and Drury to Yankees
Three-Way Trade Sends Souza to Diamondbacks and Drury to Yankees
Eric Hosmer Agrees to Eight-Year Deal with San Diego Padres
Eric Hosmer Agrees to Eight-Year Deal with San Diego Padres
Report: Eduardo Nunez and Red Sox Agree to Deal for One Year
Report: Eduardo Nunez and Red Sox Agree to Deal for One Year
Los Angeles Angels Plan to Use Shohei Ohtani in Six-Man Rotation
Los Angeles Angels Plan to Use Shohei Ohtani in Six-Man Rotation
Cubs Sign Free Agent Yu Darvish
Cubs Sign Free Agent Yu Darvish


Leave a Reply

 
© 2006-2018 BBNS.